1. Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn’s Disease 
Inbar Weinstein-Nakar, Gili Focht, Peter Church, Thomas D. Walters, Guila Abitbol, Sudha Anupindi, Laureline Berteloot, Jessie M. Hulst, Frank Ruemmele, Daniel A. Lemberg, Steven T. Leach, Ruth Cytter, Mary-Louise Greer, Anne M. Griffiths, Dan Turner 
Clinical Gastroenterology and Hepatology 
Volume 16, Issue 7, Pages e4 (July 2018)
DOI: /j.cgh
Copyright © 2018 AGA Institute Terms and Conditions

2. Figure 1
(A) Calprotectin and disease location. (B) Calprotectin and endoscopic disease activity.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

3. Figure 2
Calprotectin (A) and CRP (B) in those with mucosal healing, transmural healing, and deep healing. DH, deep healing; MH, mucosal healing; TH, transmural healing.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

4. Clinical Gastroenterology and Hepatology 2018 16, 1089-1097.e4DOI: (10.1016/j.cgh.2018.01.024)
Copyright © 2018 AGA Institute Terms and Conditions

5. Clinical Gastroenterology and Hepatology 2018 16, 1089-1097.e4DOI: (10.1016/j.cgh.2018.01.024)
Copyright © 2018 AGA Institute Terms and Conditions

6. Supplementary Figure 1
Receiver operating characteristic curve for predicting mucosal healing.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

7. Supplementary Figure 2
Receiver operating characteristic curve for predicting transmural healing.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions

8. Supplementary Figure 3
Receiver operating characteristic curve for predicting deep healing.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2018 AGA Institute Terms and Conditions